0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non Invasive Colon Cancer Screening Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-22M5642
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Non Invasive Colon Cancer Screening Market Insights Forecast to 2028
BUY CHAPTERS

Global Non Invasive Colon Cancer Screening Market Research Report 2025

Code: QYRE-Auto-22M5642
Report
June 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non Invasive Colon Cancer Screening Market

The global market for Non Invasive Colon Cancer Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Non Invasive Colon Cancer Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Non Invasive Colon Cancer Screening is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Non Invasive Colon Cancer Screening in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Non Invasive Colon Cancer Screening include Abbott Laboratories, Beckman Coulter, Inc., Epigenomics AG, Sysmex Corporation, Quest Diagnostics, Exact Sciences Corporation, Novigenix SA, CML Healthcare, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non Invasive Colon Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non Invasive Colon Cancer Screening.
The Non Invasive Colon Cancer Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non Invasive Colon Cancer Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non Invasive Colon Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Non Invasive Colon Cancer Screening Market Report

Report Metric Details
Report Name Non Invasive Colon Cancer Screening Market
Segment by Type
  • Fecal Immunochemical Test (FIT)
  • Guaiac-based Fecal Occult Blood Test (gFOBT)
Segment by Application
  • Hospitals
  • Speciality Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Beckman Coulter, Inc., Epigenomics AG, Sysmex Corporation, Quest Diagnostics, Exact Sciences Corporation, Novigenix SA, CML Healthcare, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Non Invasive Colon Cancer Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non Invasive Colon Cancer Screening Market report?

Ans: The main players in the Non Invasive Colon Cancer Screening Market are Abbott Laboratories, Beckman Coulter, Inc., Epigenomics AG, Sysmex Corporation, Quest Diagnostics, Exact Sciences Corporation, Novigenix SA, CML Healthcare, Inc.

What are the Application segmentation covered in the Non Invasive Colon Cancer Screening Market report?

Ans: The Applications covered in the Non Invasive Colon Cancer Screening Market report are Hospitals, Speciality Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others

What are the Type segmentation covered in the Non Invasive Colon Cancer Screening Market report?

Ans: The Types covered in the Non Invasive Colon Cancer Screening Market report are Fecal Immunochemical Test (FIT), Guaiac-based Fecal Occult Blood Test (gFOBT)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non Invasive Colon Cancer Screening Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fecal Immunochemical Test (FIT)
1.2.3 Guaiac-based Fecal Occult Blood Test (gFOBT)
1.3 Market by Application
1.3.1 Global Non Invasive Colon Cancer Screening Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Diagnostic Centers
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non Invasive Colon Cancer Screening Market Perspective (2020-2031)
2.2 Global Non Invasive Colon Cancer Screening Growth Trends by Region
2.2.1 Global Non Invasive Colon Cancer Screening Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Non Invasive Colon Cancer Screening Historic Market Size by Region (2020-2025)
2.2.3 Non Invasive Colon Cancer Screening Forecasted Market Size by Region (2026-2031)
2.3 Non Invasive Colon Cancer Screening Market Dynamics
2.3.1 Non Invasive Colon Cancer Screening Industry Trends
2.3.2 Non Invasive Colon Cancer Screening Market Drivers
2.3.3 Non Invasive Colon Cancer Screening Market Challenges
2.3.4 Non Invasive Colon Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non Invasive Colon Cancer Screening Players by Revenue
3.1.1 Global Top Non Invasive Colon Cancer Screening Players by Revenue (2020-2025)
3.1.2 Global Non Invasive Colon Cancer Screening Revenue Market Share by Players (2020-2025)
3.2 Global Non Invasive Colon Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Non Invasive Colon Cancer Screening Revenue
3.4 Global Non Invasive Colon Cancer Screening Market Concentration Ratio
3.4.1 Global Non Invasive Colon Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non Invasive Colon Cancer Screening Revenue in 2024
3.5 Global Key Players of Non Invasive Colon Cancer Screening Head office and Area Served
3.6 Global Key Players of Non Invasive Colon Cancer Screening, Product and Application
3.7 Global Key Players of Non Invasive Colon Cancer Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non Invasive Colon Cancer Screening Breakdown Data by Type
4.1 Global Non Invasive Colon Cancer Screening Historic Market Size by Type (2020-2025)
4.2 Global Non Invasive Colon Cancer Screening Forecasted Market Size by Type (2026-2031)
5 Non Invasive Colon Cancer Screening Breakdown Data by Application
5.1 Global Non Invasive Colon Cancer Screening Historic Market Size by Application (2020-2025)
5.2 Global Non Invasive Colon Cancer Screening Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Non Invasive Colon Cancer Screening Market Size (2020-2031)
6.2 North America Non Invasive Colon Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Non Invasive Colon Cancer Screening Market Size by Country (2020-2025)
6.4 North America Non Invasive Colon Cancer Screening Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non Invasive Colon Cancer Screening Market Size (2020-2031)
7.2 Europe Non Invasive Colon Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Non Invasive Colon Cancer Screening Market Size by Country (2020-2025)
7.4 Europe Non Invasive Colon Cancer Screening Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non Invasive Colon Cancer Screening Market Size (2020-2031)
8.2 Asia-Pacific Non Invasive Colon Cancer Screening Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2020-2025)
8.4 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non Invasive Colon Cancer Screening Market Size (2020-2031)
9.2 Latin America Non Invasive Colon Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Non Invasive Colon Cancer Screening Market Size by Country (2020-2025)
9.4 Latin America Non Invasive Colon Cancer Screening Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non Invasive Colon Cancer Screening Market Size (2020-2031)
10.2 Middle East & Africa Non Invasive Colon Cancer Screening Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2020-2025)
10.4 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Non Invasive Colon Cancer Screening Introduction
11.1.4 Abbott Laboratories Revenue in Non Invasive Colon Cancer Screening Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter, Inc.
11.2.1 Beckman Coulter, Inc. Company Details
11.2.2 Beckman Coulter, Inc. Business Overview
11.2.3 Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Introduction
11.2.4 Beckman Coulter, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2020-2025)
11.2.5 Beckman Coulter, Inc. Recent Development
11.3 Epigenomics AG
11.3.1 Epigenomics AG Company Details
11.3.2 Epigenomics AG Business Overview
11.3.3 Epigenomics AG Non Invasive Colon Cancer Screening Introduction
11.3.4 Epigenomics AG Revenue in Non Invasive Colon Cancer Screening Business (2020-2025)
11.3.5 Epigenomics AG Recent Development
11.4 Sysmex Corporation
11.4.1 Sysmex Corporation Company Details
11.4.2 Sysmex Corporation Business Overview
11.4.3 Sysmex Corporation Non Invasive Colon Cancer Screening Introduction
11.4.4 Sysmex Corporation Revenue in Non Invasive Colon Cancer Screening Business (2020-2025)
11.4.5 Sysmex Corporation Recent Development
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Details
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Non Invasive Colon Cancer Screening Introduction
11.5.4 Quest Diagnostics Revenue in Non Invasive Colon Cancer Screening Business (2020-2025)
11.5.5 Quest Diagnostics Recent Development
11.6 Exact Sciences Corporation
11.6.1 Exact Sciences Corporation Company Details
11.6.2 Exact Sciences Corporation Business Overview
11.6.3 Exact Sciences Corporation Non Invasive Colon Cancer Screening Introduction
11.6.4 Exact Sciences Corporation Revenue in Non Invasive Colon Cancer Screening Business (2020-2025)
11.6.5 Exact Sciences Corporation Recent Development
11.7 Novigenix SA
11.7.1 Novigenix SA Company Details
11.7.2 Novigenix SA Business Overview
11.7.3 Novigenix SA Non Invasive Colon Cancer Screening Introduction
11.7.4 Novigenix SA Revenue in Non Invasive Colon Cancer Screening Business (2020-2025)
11.7.5 Novigenix SA Recent Development
11.8 CML Healthcare, Inc.
11.8.1 CML Healthcare, Inc. Company Details
11.8.2 CML Healthcare, Inc. Business Overview
11.8.3 CML Healthcare, Inc. Non Invasive Colon Cancer Screening Introduction
11.8.4 CML Healthcare, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2020-2025)
11.8.5 CML Healthcare, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Non Invasive Colon Cancer Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Fecal Immunochemical Test (FIT)
 Table 3. Key Players of Guaiac-based Fecal Occult Blood Test (gFOBT)
 Table 4. Global Non Invasive Colon Cancer Screening Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Non Invasive Colon Cancer Screening Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Non Invasive Colon Cancer Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Non Invasive Colon Cancer Screening Market Share by Region (2020-2025)
 Table 8. Global Non Invasive Colon Cancer Screening Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Non Invasive Colon Cancer Screening Market Share by Region (2026-2031)
 Table 10. Non Invasive Colon Cancer Screening Market Trends
 Table 11. Non Invasive Colon Cancer Screening Market Drivers
 Table 12. Non Invasive Colon Cancer Screening Market Challenges
 Table 13. Non Invasive Colon Cancer Screening Market Restraints
 Table 14. Global Non Invasive Colon Cancer Screening Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Non Invasive Colon Cancer Screening Market Share by Players (2020-2025)
 Table 16. Global Top Non Invasive Colon Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Invasive Colon Cancer Screening as of 2024)
 Table 17. Ranking of Global Top Non Invasive Colon Cancer Screening Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Non Invasive Colon Cancer Screening Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Non Invasive Colon Cancer Screening, Headquarters and Area Served
 Table 20. Global Key Players of Non Invasive Colon Cancer Screening, Product and Application
 Table 21. Global Key Players of Non Invasive Colon Cancer Screening, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Non Invasive Colon Cancer Screening Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Non Invasive Colon Cancer Screening Revenue Market Share by Type (2020-2025)
 Table 25. Global Non Invasive Colon Cancer Screening Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Non Invasive Colon Cancer Screening Revenue Market Share by Type (2026-2031)
 Table 27. Global Non Invasive Colon Cancer Screening Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Non Invasive Colon Cancer Screening Revenue Market Share by Application (2020-2025)
 Table 29. Global Non Invasive Colon Cancer Screening Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Non Invasive Colon Cancer Screening Revenue Market Share by Application (2026-2031)
 Table 31. North America Non Invasive Colon Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Non Invasive Colon Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Non Invasive Colon Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Non Invasive Colon Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Non Invasive Colon Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Non Invasive Colon Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Non Invasive Colon Cancer Screening Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non Invasive Colon Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Non Invasive Colon Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Non Invasive Colon Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Non Invasive Colon Cancer Screening Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Laboratories Company Details
 Table 47. Abbott Laboratories Business Overview
 Table 48. Abbott Laboratories Non Invasive Colon Cancer Screening Product
 Table 49. Abbott Laboratories Revenue in Non Invasive Colon Cancer Screening Business (2020-2025) & (US$ Million)
 Table 50. Abbott Laboratories Recent Development
 Table 51. Beckman Coulter, Inc. Company Details
 Table 52. Beckman Coulter, Inc. Business Overview
 Table 53. Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Product
 Table 54. Beckman Coulter, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2020-2025) & (US$ Million)
 Table 55. Beckman Coulter, Inc. Recent Development
 Table 56. Epigenomics AG Company Details
 Table 57. Epigenomics AG Business Overview
 Table 58. Epigenomics AG Non Invasive Colon Cancer Screening Product
 Table 59. Epigenomics AG Revenue in Non Invasive Colon Cancer Screening Business (2020-2025) & (US$ Million)
 Table 60. Epigenomics AG Recent Development
 Table 61. Sysmex Corporation Company Details
 Table 62. Sysmex Corporation Business Overview
 Table 63. Sysmex Corporation Non Invasive Colon Cancer Screening Product
 Table 64. Sysmex Corporation Revenue in Non Invasive Colon Cancer Screening Business (2020-2025) & (US$ Million)
 Table 65. Sysmex Corporation Recent Development
 Table 66. Quest Diagnostics Company Details
 Table 67. Quest Diagnostics Business Overview
 Table 68. Quest Diagnostics Non Invasive Colon Cancer Screening Product
 Table 69. Quest Diagnostics Revenue in Non Invasive Colon Cancer Screening Business (2020-2025) & (US$ Million)
 Table 70. Quest Diagnostics Recent Development
 Table 71. Exact Sciences Corporation Company Details
 Table 72. Exact Sciences Corporation Business Overview
 Table 73. Exact Sciences Corporation Non Invasive Colon Cancer Screening Product
 Table 74. Exact Sciences Corporation Revenue in Non Invasive Colon Cancer Screening Business (2020-2025) & (US$ Million)
 Table 75. Exact Sciences Corporation Recent Development
 Table 76. Novigenix SA Company Details
 Table 77. Novigenix SA Business Overview
 Table 78. Novigenix SA Non Invasive Colon Cancer Screening Product
 Table 79. Novigenix SA Revenue in Non Invasive Colon Cancer Screening Business (2020-2025) & (US$ Million)
 Table 80. Novigenix SA Recent Development
 Table 81. CML Healthcare, Inc. Company Details
 Table 82. CML Healthcare, Inc. Business Overview
 Table 83. CML Healthcare, Inc. Non Invasive Colon Cancer Screening Product
 Table 84. CML Healthcare, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2020-2025) & (US$ Million)
 Table 85. CML Healthcare, Inc. Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Non Invasive Colon Cancer Screening Picture
 Figure 2. Global Non Invasive Colon Cancer Screening Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non Invasive Colon Cancer Screening Market Share by Type: 2024 VS 2031
 Figure 4. Fecal Immunochemical Test (FIT) Features
 Figure 5. Guaiac-based Fecal Occult Blood Test (gFOBT) Features
 Figure 6. Global Non Invasive Colon Cancer Screening Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Non Invasive Colon Cancer Screening Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Speciality Clinics Case Studies
 Figure 10. Ambulatory Surgical Centers Case Studies
 Figure 11. Diagnostic Centers Case Studies
 Figure 12. Others Case Studies
 Figure 13. Non Invasive Colon Cancer Screening Report Years Considered
 Figure 14. Global Non Invasive Colon Cancer Screening Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Non Invasive Colon Cancer Screening Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Non Invasive Colon Cancer Screening Market Share by Region: 2024 VS 2031
 Figure 17. Global Non Invasive Colon Cancer Screening Market Share by Players in 2024
 Figure 18. Global Top Non Invasive Colon Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Invasive Colon Cancer Screening as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Non Invasive Colon Cancer Screening Revenue in 2024
 Figure 20. North America Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Non Invasive Colon Cancer Screening Market Share by Country (2020-2031)
 Figure 22. United States Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Non Invasive Colon Cancer Screening Market Share by Country (2020-2031)
 Figure 26. Germany Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Non Invasive Colon Cancer Screening Market Share by Region (2020-2031)
 Figure 34. China Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Non Invasive Colon Cancer Screening Market Share by Country (2020-2031)
 Figure 42. Mexico Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Non Invasive Colon Cancer Screening Market Share by Country (2020-2031)
 Figure 46. Turkey Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Non Invasive Colon Cancer Screening Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Abbott Laboratories Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2020-2025)
 Figure 50. Beckman Coulter, Inc. Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2020-2025)
 Figure 51. Epigenomics AG Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2020-2025)
 Figure 52. Sysmex Corporation Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2020-2025)
 Figure 53. Quest Diagnostics Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2020-2025)
 Figure 54. Exact Sciences Corporation Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2020-2025)
 Figure 55. Novigenix SA Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2020-2025)
 Figure 56. CML Healthcare, Inc. Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network